Bellerophon Therapeutics
BLPH
$0.05130
Share price
-6.90%
Change (1 day)
-99.34%
Change (1 year)
Categories
Bellerophon Therapeutics (BLPH) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $1.25 M
According to Bellerophon Therapeutics 's latest financial reports the company's total liabilities are $1.25 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Bellerophon Therapeutics - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $5.4 M | 2.76% |
| 2021-12-31 | $5.25 M | -56.16% |
| 2020-12-31 | $11.99 M | 25.99% |
| 2019-12-31 | $9.51 M | -34.38% |
| 2018-12-31 | $14.5 M | -63.19% |
| 2017-12-31 | $39.4 M | 236.5% |
| 2016-12-31 | $11.71 M | 45.05% |
| 2015-12-31 | $8.07 M | -22.78% |
| 2014-12-31 | $10.45 M | -46.04% |
| 2013-12-31 | $19.37 M | 33.93% |
| 2012-12-31 | $14.46 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $34.38 B | 2,737,718.47% | 🇺🇸 USA |
 Baxter BAX | $19.80 B | 1,576,970.06% | 🇺🇸 USA |
 Lantheus Holdings LNTH | $0.83 B | 66,401.35% | 🇺🇸 USA |
 Abeona Therapeutics
ABEO | $49.17 M | 3,815.29% | 🇺🇸 USA |